Capecitabine
Capecitabine (CAS: 154361-50-9) is a white to off-white crystalline antineoplastic active ingredient, an oral fluoropyrimidine carbamate prodrug of 5-fluorouracil. It is used in the treatment of breast, colorectal, and gastric cancers, where it is converted selectively in tumor tissue to active 5-FU. As a bulk API it is formulated into film-coated tablets for oral chemotherapy regimens. The compound is heat-sensitive and is stored under controlled temperature with protection from light and moisture. Buyers procure capecitabine for generic oncology production where compendial quality standards are essential.
• Oncology API: an oral prodrug of 5-fluorouracil for breast, colorectal, and gastric cancer therapy.
• Tumor-selective: enzymatically activated preferentially in tumor tissue to active 5-FU.
• Formulation: supplied as a crystalline powder for film-coated tablet manufacture.
• Storage: heat-sensitive; stored at controlled temperature protected from light and moisture.
Product Name: Capecitabine
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.